After the discovery of the effects of testosterone on muscle strength and hypertrophy, a synthetic formula of this hormone was developed in the late 1930s and came to be called androgenic-anabolic steroids (AAS). 1 These drugs have been used legally by particular individuals, such as the elderly, patients with acquired immunodeficiency syndrome, hypogonadism, anemia that accompanies renal failure, bone marrow failure, endometriosis, cancer and osteoporosis. 2 The use of AAS by young sports practitioners has increased due to the need to obtain results in the short term, such as breaking records in competitions, and for muscle hypertrophy, either for aesthetic or bodybuilding purposes. 3,4 However, these substances are known to be associated with adverse effects, including acne, testicular atrophy, mood changes, water retention and gynecomastia. The prevalence of use of AAS varies across geographic regions, ranging from 0.2% in Asia, 4.8% in South America, reaching 21.7% in the Middle East. 5In addition, biochemical changes induced by AAS can promote changes in the lipid profile, characterized by a
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.